{"id":"W4386945206","doi":"10.1080/13543776.2023.2262136","title":"Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"TRIUMF; University of British Columbia; University of Alberta","funders":"","keywords":"Trk receptor; Medicine; Precision medicine; Pharmacology; Bioinformatics; Cancer research; Computational biology; Biology; Receptor; Internal medicine; Neurotrophin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002811658,0.000608758,0.0009730664,0.0002067085,0.00009795088,0.00003112999,0.0005096289,0.0005768192,0.00019541],"category_scores_gemma":[0.00007591548,0.0004928819,0.0005946186,0.0005103305,0.0001015904,0.000006848461,0.0002115626,0.0002959396,0.000481165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008824098,"about_ca_system_score_gemma":0.000238132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002350539,"about_ca_topic_score_gemma":0.000001055277,"domain_scores_codex":[0.9969854,0.0004120122,0.0009265413,0.000808672,0.0004589722,0.000408432],"domain_scores_gemma":[0.9982476,0.00002581086,0.0006017953,0.0008301432,0.0001320394,0.0001626089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001724974,0.0003371388,0.000005343734,0.0009379995,0.0005111337,0.000004220737,0.00004680745,9.946278e-7,0.005833324,0.00008690486,0.03338318,0.9586805],"study_design_scores_gemma":[0.000506976,0.0006497138,0.000002370254,0.00279868,0.00002627678,0.000005170683,0.00003112226,0.000002829586,0.01101369,0.000016286,0.9844499,0.0004969442],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001449085,0.9942179,0.00002121457,0.0001109674,0.004189871,0.001024875,0.0001603149,0.0000586768,0.00007121069],"genre_scores_gemma":[0.0001411974,0.9942414,0.00006347305,0.0003116479,0.0008621452,0.0002460333,0.003028705,0.0001581471,0.0009472123],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9581835,"threshold_uncertainty_score":0.9997523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1103937892736046,"score_gpt":0.3584458892396905,"score_spread":0.2480520999660859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}